Table 1.
Deregulated mark | Change in cancer | Modifier | Associated with | References |
---|---|---|---|---|
DNA methylation | Regional hypermethylation | DNMT1, DNMT3, UHRF1a | Gene repression | Herman et al. (1995) [98], Ai et al. (2006) [40], Bae et al. (2004) [41], Kornegoo et al. (2012) [99], Roll et al. (2013) [43], Zou et al. (2009) [100] |
Global hypomethylation | Genomic instability | Bedford and van Helden (1987) [101], Cadieux et al. (2006) [102], Feinberg and Vogelstein (1983) [74], Fraga et al. (2005) [103], Mudbhary et al. (2014) [5], Rauch et al. (2008) [104] | ||
Activation of retrotransposons | Jackson-Grusby et al. (2001) [105], Howard et al. (2007) [106], Minoguchi and Iba (2008) [107] | |||
H3K9me3 | Hypermethylation | G9a, SETDB1, SUV39H1 | Increased gene repression | Frigola et al. (2006) [108], Nguyen et al. (2002) [109] |
H3k27me2–me3 | Hypermethylation | EZH1, EZH2 | DNA hypermethylation | Chinaranagari et al. (2014) [110], Ohm et al. (2007) [111], Popovic et al. (2014) [112], Schlesinger et al. (2007) [113] |
H3K4me3 | Hypomethylation | MLL4 | Gene repression | Kang et al. (2015) [114], Nguyen et al. (2002) [109], Lee et al. (2013) [115] |
List of common epigenetic marks and their analogous regulators are shown in relation to reported changes in chromatin or gene expression resulting from their misregulation
Although it does not modify the DNA methylome, UHRF1 is an essential necessary component of the DNMT1 complex